Sponsor

Burzynski Research Institute

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Burzynski Research Institute appears in 14 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials14
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

14 shown
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate CancerNCT00003534 · lead sponsor · 1996-10-11
WITHDRAWN
Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerNCT00003497 · lead sponsor · 1996-08-21
TERMINATED
Antineoplaston Therapy in Treating Patients With Stage IV Lung CancerNCT00003492 · lead sponsor · 1996-04-10
TERMINATED
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung CancerNCT00003495 · lead sponsor · 1996-03-27
TERMINATED
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerNCT00003516 · lead sponsor · 1996-03-27
TERMINATED
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung CancerNCT00003494 · lead sponsor · 1996-03-26
TERMINATED
Antineoplaston Therapy in Treating Patients With Stage IV Lung CancerNCT00003491 · lead sponsor · 1996-03-20
TERMINATED
Antineoplaston Therapy in Treating Women With Stage IV Breast CancerNCT00003454 · lead sponsor · 1996-03-18
TERMINATED
Antineoplaston Therapy in Treating Patients With Advanced MesotheliomaNCT00003508 · lead sponsor · 1996-03-08
TERMINATED
Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung CancerNCT00003496 · lead sponsor · 1996-03-07
TERMINATED
Antineoplaston Therapy in Treating Patients With Metastatic Prostate CancerNCT00003533 · lead sponsor · 1996-02-27
TERMINATED
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerNCT00003536 · lead sponsor
WITHDRAWN
Antineoplaston Therapy in Treating Women With Advanced Breast CancerNCT00003455 · lead sponsor
WITHDRAWN
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerNCT00003517 · lead sponsor
WITHDRAWN

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Burzynski Research Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
bicalutamide1
flutamide1
leuprolide acetate1
methotrexate1

Sponsor roles

lead sponsor14
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.